Brokers Set Expectations for Tilray Inc’s Q1 2025 Earnings (NASDAQ:TLRY)

Tilray Inc (NASDAQ:TLRY) – Investment analysts at Roth Capital reduced their Q1 2025 EPS estimates for Tilray in a research report issued to clients and investors on Tuesday, October 8th. Roth Capital analyst W. Kirk now anticipates that the company will earn ($0.10) per share for the quarter, down from their previous estimate of ($0.09). The consensus estimate for Tilray’s current full-year earnings is ($0.16) per share. Roth Capital also issued estimates for Tilray’s FY2025 earnings at ($0.34) EPS.

Tilray (NASDAQ:TLRY) last issued its earnings results on Thursday, October 10th. The company reported ($0.04) earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of ($0.04). Tilray had a negative net margin of 26.79% and a negative return on equity of 2.01%. The company had revenue of $200.00 million for the quarter, compared to analysts’ expectations of $218.70 million. During the same period in the prior year, the firm earned ($0.10) EPS. Tilray’s quarterly revenue was up 13.0% compared to the same quarter last year.

Separately, Roth Mkm dropped their price target on Tilray from $2.00 to $1.75 and set a “neutral” rating on the stock in a research note on Friday.

Tilray Stock Performance

NASDAQ:TLRY opened at $1.63 on Friday. The company has a debt-to-equity ratio of 0.10, a quick ratio of 1.42 and a current ratio of 2.27. Tilray has a 12-month low of $1.45 and a 12-month high of $2.97. The stock’s 50 day moving average price is $1.75 and its two-hundred day moving average price is $1.86.

Hedge Funds Weigh In On Tilray

A number of large investors have recently made changes to their positions in the company. Creative Planning increased its position in Tilray by 36.6% during the third quarter. Creative Planning now owns 141,921 shares of the company’s stock worth $250,000 after acquiring an additional 38,054 shares during the period. Newbridge Financial Services Group Inc. raised its position in shares of Tilray by 54.8% in the second quarter. Newbridge Financial Services Group Inc. now owns 52,067 shares of the company’s stock valued at $86,000 after buying an additional 18,423 shares in the last quarter. Sanctuary Advisors LLC bought a new stake in shares of Tilray in the second quarter valued at approximately $65,000. Algert Global LLC acquired a new stake in Tilray during the second quarter worth approximately $130,000. Finally, The Manufacturers Life Insurance Company increased its stake in Tilray by 11.5% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 682,478 shares of the company’s stock worth $1,131,000 after acquiring an additional 70,605 shares during the period. Institutional investors own 9.35% of the company’s stock.

About Tilray

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.